Covid-19: Two more drugs recommended for use by WHO


By AGENCY
A healthcare worker attaches an intravenous (IV) infusion for a monoclonal antibody treatment to a patient’s hand in the parking lot of a hospital in Detroit, United States. The WHO conditionally approved an additional monoclonal antibody to treat Covid-19, as well as another drug used to treat rheumatoid arthritis. — Bloomberg

The drug baricitinib is strongly recommended for patients with severe or critical Covid-19, in combination with corticosteroids, said a World Health Organization (WHO) Guideline Development Group of international experts in The BMJ medical journal on Jan 13 (2022).

Their strong recommendation is based on evidence of moderate certainty that it improves survival and reduces the need for ventilation, with no observed increase in adverse effects.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

Updates for prostate screening recommendation
Learning how to age well
BCG vaccine could help counter dementia
Surgery options for complex heart valve cases
Managing mum’s depression helps baby’s emotional development
Teaching children about 'safe touch'
Faking symptoms to get antibiotics
Premature babies: Their fight to survive�
Diabetic retinopathy: When diabetes steals your sight
Plant proteins can help boost testosterone

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read